Trial Profile
A Comparison of the Safety and Comfort of AC-170
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Sep 2017
Price :
$35
*
At a glance
- Drugs Cetirizine (Primary) ; Olopatadine
- Indications Allergic conjunctivitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Aciex Therapeutics
- 22 Apr 2014 New trial record